Z-0455-2022 Class II Terminated
FDA device recall Z-0455-2022 was initiated by Qiagen Sciences LLC on Nov 8, 2021 and is designated Class II. Reason for recall: The firm identified sixteen (16) faulty cartridges in LOT 210209, which contain incorrect primer-probe mixes in the reaction chambers. If an affected cartridge is used, false-negative, false-positive… The recall status is terminated (terminated Mar 29, 2023). Affected quantity: 376 kits.
Recall details
- Product Type
- Devices
- Report Date
- Jan 12, 2022
- Initiation Date
- Nov 8, 2021
- Termination Date
- Mar 29, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 376 kits
Product description
QIAstat-Dx Respiratory SARS-CoV-2 Panel (US IVD under FDA EUA 200075); REF 691223
Reason for recall
The firm identified sixteen (16) faulty cartridges in LOT 210209, which contain incorrect primer-probe mixes in the reaction chambers. If an affected cartridge is used, false-negative, false-positive, or both false-negative and false-positive results could occur.
Distribution pattern
Domestic distribution to AL, DC, KY, MD, ME, NJ, OK< PA, and TX. No foreign distribution.
Code information
LOT 210209 UDI (01)14053228038846(17)211127(10)210209(24)691223 Serial Numbers: 412092551 412092559 412092552 412092560 412092553 412092561 412092554 412092563 412092555 412092564 412092556 412092565 412092557 412092566 412092558 412092567
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-0455-2022
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026